Eprecis 5 mg Solution is a Health Canada–registered veterinary drug (DIN 02527057) held by Ceva Animal Health Inc, containing Eprinomectin. Health Canada lists its status as Marketed (status date 17 Apr 2024). Nexara Health has matched 17 registrations of Eprinomectin across 5 other regulated markets.
Health Canada registration
| DIN | 02527057 |
|---|---|
| Brand name | Eprecis |
| Active ingredient | Eprinomectin |
| Strength | 5 mg |
| Dosage form | Solution |
| Route | Topical |
| Company | Ceva Animal Health Inc |
| Status | Marketed — 17 Apr 2024 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Eprinomectin registered in other markets
17 registrations of the same molecule in 5 national registries outside Canada (first 16 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Denmark | Eprecis Vet. | Ceva Sante Animale | 20 mg/ml | injektionsvæske, opløsning | Decentral procedure | Laegemiddelstyrelsen |
| Denmark | Eprinex Vet. | Boehringer Ingelheim Animal Health Nordics A/S | 5 mg/ml | pour-on, opløsning | MRP | Laegemiddelstyrelsen |
| Denmark | Neoprinil pour-on | Virbac S.A. | 5 mg/ml | pour-on, opløsning | Decentral procedure | Laegemiddelstyrelsen |
| Denmark | Pereprin | Huvepharma | 5 mg/ml | pour-on, opløsning | Decentral procedure | Laegemiddelstyrelsen |
| Denmark | Zepromec | Chanelle Pharmaceuticals Manufacturing Limited | 5 mg/ml | pour-on, opløsning | MRP | Laegemiddelstyrelsen |
| European Union (EMA) | Longrange | Merial | Refused | EMA centrally authorised | ||
| Malaysia | EPRECIS 20 mg/ml solution for injection | Ceva Animal Health Malaysia Sdn. Bhd. | Veterinary | PRODUCT APPROVED | NPRA | |
| Poland | Elivec | Industrial Veterinaria, S.A. | 5 mg/ml | Roztwór do polewania | Bezterminowe | URPL RPL |
| Poland | Eprecis | Ceva Animal Health Polska Sp. z o.o. | 5 mg/ml | Roztwór do polewania | Bezterminowe | URPL RPL |
| Poland | Eprecis | Ceva Animal Health Polska Sp. z o.o. | 20 mg/ml | Roztwór do wstrzykiwań | Bezterminowe | URPL RPL |
| Poland | Eprinex Multi | Boehringer Ingelheim Animal Health France SCS | 5 mg/ml | Roztwór do polewania | Bezterminowe | URPL RPL |
| Poland | Eprivalan | Boehringer Ingelheim Animal Health France SCS | 5,0 mg/ml | Roztwór do polewania | 2021-09-24 | URPL RPL |
| Poland | Eprizero | Norbrook Laboratories (Ireland) Limited | 5 mg/ml | Roztwór do polewania | Bezterminowe | URPL RPL |
| Poland | Epromec | Chanelle Pharmaceuticals Manufacturing Ltd. | 5 mg/ml | Roztwór do polewania | Bezterminowe | URPL RPL |
| Poland | Neoprinil Pour-On | Virbac S.A. | 5 mg/ml | Roztwór do polewania | Bezterminowe | URPL RPL |
| United States | Eprinomectin | Zhejiang Hisun Pharmaceutical Co., Ltd. | Powder | FDA NDC |
See every manufacturer of Eprinomectin worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. Because this DIN is marketed in Canada, supply normally comes through the Canadian channel; where the Canadian presentation is short or discontinued, the registrations above show which regulated markets hold an equivalent that can be imported under the Special Access Programme or for clinical comparator use. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Eprecis (DIN 02527057) marketed in Canada?
Yes. Health Canada lists DIN 02527057 as Marketed as of 17 Apr 2024.
Who holds the Canadian licence for this product?
Ceva Animal Health Inc is the company of record in the Health Canada Drug Product Database.
Is Eprinomectin registered outside Canada?
Yes — Nexara Health has matched 17 registrations in 5 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02527057, status date 2024-04-17; national medicine registries: EMA centrally authorised, FDA NDC, Laegemiddelstyrelsen, NPRA, URPL RPL. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02527057, status date 2024-04-17; national medicine registries: EMA centrally authorised, FDA NDC, Laegemiddelstyrelsen, NPRA, URPL RPL.
Health Canada Drug Product Database (DPD), DIN 02527057, status date 2024-04-17; national medicine registries: EMA centrally authorised, FDA NDC, Laegemiddelstyrelsen, NPRA, URPL RPL. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.